A federal appeals court revived hundreds of private lawsuits against Kenvue and many pharmacies/retailers, alleging that Tylenol causes autism and ADHD. The decision reopens substantial litigation risk for Kenvue, potentially increasing legal and settlement costs and keeping uncertainty high for impacted retail partners.
A federal appeals court revived hundreds of private lawsuits against Kenvue and many pharmacies/retailers, alleging that Tylenol causes autism and ADHD. The decision reopens substantial litigation risk for Kenvue, potentially increasing legal and settlement costs and keeping uncertainty high for impacted retail partners.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
